GPIHBP1分子与血浆中甘油三酯脂蛋白脂解代谢研究进展

doi:10.11843/j.issn.0366-6964.2013.05.001

摘要/Abstract

摘要：

脂蛋白酯酶（Lipoprotein lipase, LPL）主要由脂肪和肌肉组织的实质细胞产生，脂解毛细血管中血浆脂蛋白的甘油三酯。多年来，关于LPL是如何从细胞间隙转运至毛细血管内皮细胞上，一直不清楚。最新研究结果表明，在LPL从细胞间隙向毛细血管内皮细胞转运的过程中，糖基化磷脂酰肌醇锚定高密度脂蛋白结合蛋白1（Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1, GPIHBP1）发挥着重要的作用。当GPIHBP1缺失时，LPL被错误定位于细胞间隙，导致动物机体出现严重的高甘油三酯血症。Gpihbp1基因突变可致人患高甘油三酯血症。本文就GPIHBP1分子在动物机体健康和疾病状况下的生理作用机理的研究进展进行了综述，同时也对富含甘油三酯脂蛋白脂解代谢中一些尚需解决的问题进行了讨论。

Abstract:

Lipoprotein lipase (LPL) is produced by parenchymal cells from mainly adipocytes and myocytes, but it is involved in hydrolysing triglycerides in plasma lipoproteins at the capillary lumen. For decades, the mechanism by which LPL reaches its site of action in capillaries was unclear, but the problem was recently solved. Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) picks up LPL from the interstitial spaces across endothelial cells to the capillary lumen. When GPIHBP1 is absent, LPL is mislocalized to the interstitial spaces, which lead to severe hypertriglyceridaemia. Some cases of hypertriglyceridaemia in humans are caused by Gpihbp1 mutations that interfere with the ability of GPIHBP1 to bind to LPL. Here, we review recent progress in understanding the role of GPIHBP1 in health and disease and discuss some remaining unresolved issues regarding the processing of triglyceride-rich lipoproteins.

中图分类号:

S813.3

姜延志，岑王敏，邢淑华，陈建宁，李学伟. GPIHBP1分子与血浆中甘油三酯脂蛋白脂解代谢研究进展[J]. 畜牧兽医学报, 2013, 44(5): 665-672.

JIANG Yan-zhi, CEN Wang-min, XING Shu-hua, CHEN Jian-ning, LI Xue-wei. New Insights in GPIHBP1 and the Intravascular Processing of Triglyceride-rich Lipoproteins[J]. ACTA VETERINARIA ET ZOOTECHNICA SINICA, 2013, 44(5): 665-672.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: https://www.xmsyxb.com/CN/ 10.11843/j.issn.0366-6964.2013.05.001

https://www.xmsyxb.com/CN/Y2013/V44/I5/665

参考文献

［1］MERKEL M, ECKEL R H, GOLDBERG I J. Lipoprotein lipase: genetics, lipid uptake, and regulation ［J］. J Lipid Res, 2002, 43(12): 1997-2006.

［2］WANG H, ECKEL R H. Lipoprotein lipase: from gene to obesity ［J］. Am J Physiol Endocrinol Metab, 2009, 297(2): E271-288.

［3］CISAR L A, HOOGEWERF A J, CUPP M, et al. Secretion and degradation of lipoprotein lipase in cultured adipocytes. Binding of lipoprotein lipase to membrane heparan sulfate proteoglycans is necessary for degradation ［J］. J Biol Chem, 1989, 264(3): 1767-1774.

［4］BERRYMAN D E, BENSADOUN A. Heparan sulfate proteoglycans are primarily responsible for the maintenance of enzyme activity, binding, and degradation of lipoprotein lipase in Chinese hamster ovary cells ［J］. J Biol Chem, 1995, 270(41): 24525-24531.

［5］LOOKENE A, SAVONEN R, OLIVECRONA G. Interaction of lipoproteins with heparan sulfate proteoglycans and with lipoprotein lipase. Studies by surface plasmon resonance technique ［J］. Biochemistry, 1997, 36(17): 5267-5275.

［6］BEIGNEUX A P, DAVIES B, GIN P, et al. Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons ［J］. Cell Metab, 2007, 5(4): 279-291.

［7］DAVIES B S, BEIGNEUX A P, BARNES R H 2nd, et al. GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries ［J］. Cell Metab, 2010, 12(1): 42-52.

［8］WANG J, HEGELE R A. Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650) ［J］. Lipids Health Dis, 2007, 6: 23.

［9］BEIGNEUX A P, FRANSSEN R, BENSADOUN A, et al. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase ［J］. Arterioscler Thromb Vasc Biol, 2009, 29(6): 956-962.

［10］FRANSSEN R, YOUNG S G, PEELMAN F, et al. Chylomicronemia with sow postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects ［J］. Circ Cardiovasc Genet, 2010, 3(2): 169-178.

［11］OLIVECRONA G, EHRENBORG E, SEMB H, et al. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia ［J］. J Lipid Res, 2010, 51(6): 1535-1545.

［12］COCA-PRIETO I, KROUPA O, GONZALEZ-SANTOS P, et al. Childhood-onset chylomicronaemia with reduced plasma lipoprotein lipase activity and mass: identification of a novel GPIHBP1 mutation ［J］. J Intern Med, 2011, 270(3): 224-228.

［13］CHARRIERE S, PERETTI N, BERNARD S, et al. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia ［J］. J Clin Endocrinol Metab, 2011, 96(10): E1675-1679.

［14］BEIGNEUX A P, DAVIES B S, TAT S, et al. Assessing the role of the glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) three-finger domain in binding lipoprotein lipase ［J］. J Biol Chem, 2011, 286(22): 19735-19743.

［15］RIOS J J, SHASTRY S, JASSO J, et al. Deletion of GPIHBP1 causing severe chylomicronemia ［J］. J Inherit Metab Dis, 2011, 35(3): 531-540.

［16］SURENDRAN R P, VISSER M E, HEEMELAAR S, et al. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia ［J］. J Intern Med, 2012, 272(2): 185-196.

［17］IOKA R X, KANG M J, KAMIYAMA S, et al. Expression cloning and characterization of a novel glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein, GPI-HBP1 ［J］. J Biol Chem, 2003, 278(9): 7344-7349.

［18］WONG H, DAVIS R C, THUREN T, et al. Lipoprotein lipase domain function ［J］. J Biol Chem, 1994, 269(14): 10319-10323.

［19］GIN P, YIN L, DAVIES B S, et al. The acidic domain of GPIHBP1 is important for the binding of lipoprotein lipase and chylomicrons ［J］. J Biol Chem, 2008, 284(43): 29554-29562.

［20］FRY B G, WUSTER W, KINI R M, et al. Molecular evolution and phylogeny of elapid snake venom three-finger toxins ［J］. J Mol Evol, 2003, 57(1): 110-129.

［21］BEIGNEUX A P, GIN P, DAVIES B S, et al. Highly conserved cysteines within the Ly6 domain of GPIHBP1 are crucial for the binding of lipoprotein lipase ［J］. J Biol Chem, 2009(B), 284(44): 30240-30247.

［22］BEIGNEUX A P, GIN P, DAVIES B S, et al. Glycosylation of Asn-76 in mouse GPIHBP1 is critical for its appearance on the cell surface and the binding of chylomicrons and lipoprotein lipase ［J］. J Lipid Res, 2008, 49(6): 1312-1321.

［23］GIN P, BEIGNEUX A P, VOSS C, et al. Binding preferences for GPIHBP1, a glycosylphosphatidylinositol- anchored protein of capillary endothelial cells ［J］. Arterioscler Thromb Vasc Biol, 2011, 31(1): 176-182.

［24］GIN P, GOULBOURNE C, ADEYO O, et al. Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1 ［J］. Hum Mol Genet, 2012, 21(13): 2961-2972.

［25］WEINSTEIN M M, YIN L, BEIGNEUX A P, et al. Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice ［J］. J Biol Chem, 2008, 283(50): 34511-34518.

［26］DAVIES B S, GOULBOURNE C N, BARNES R H 2nd, et al. Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells ［J］. J Lipid Res, 2012, 53(12): 2690-2697.

［27］OLAFSEN T, YOUNG S G, DAVIES B S, et al. Unexpected expression pattern for glycosylphosphatidylinositol-anchored HDL-binding protein 1 (GPIHBP1) in mouse tissues revealed by positron emission tomography scanning ［J］. J Biol Chem, 2010, 285(50): 39239-39248.

［28］WEINSTOCK P H, BISGAIER C L, AALTO-SETÄLÄ K, et al. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired low density lipoprotein clearance in heterozygotes ［J］. J Clin Invest, 1995, 96(6): 2555-2568.

［29］STRAUSS J G, FRANK S, KRATKY D, et al. Adenovirus-mediated rescue of lipoprotein lipase-deficient mice. Lipolysis of triglyceride-rich lipoproteins is essential for high density lipoprotein maturation in mice ［J］. J Biol Chem, 2001, 276(39): 36083-36090.

［30］ZHANG X, QI R, XIAN X, et al. Spontaneous atherosclerosis in aged lipoproteinl lipase deficient mice with wevere hypertriglyceridemia on a normal chow diet ［J］. Circ Res, 2008, 102(2): 250-256.

［31］WEINSTEIN M M, YIN L, TU Y, et al. Chylomicronemia elicits atherosclerosis in mice ［J］. Arterioscler Thromb Vasc Biol, 2010B, 30(1): 20-23.

［32］PLUMP A S, SMITH J D, HAYEK T, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells ［J］. Cell, 1992, 71(2): 343-353.

［33］NAKASHIMA Y, PLUMP A S, RAINES E W, et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree ［J］. Arterioscler Thromb, 1994, 14(1):133-140.

［34］BENLIAN P, DE GENNES J L, FOUBERT L, et al. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene ［J］. N Engl J Med, 1996, 335(12): 848-854.

［35］VILARO S, CAMPS L, REINA M, et al. Localization of lipoprotein lipase to discrete areas of the guinea pig brain ［J］. Brain Res, 1990, 506(2): 249-253.

［36］BESSESEN D H, RICHARDS C L, ETIENNE J, et al. Spinal cord of the rat contains more lipoprotein lipase than other brain regions ［J］. J Lipid Res, 1993, 34(2): 229-238.

［37］DAVIES B S, WAKI H, BEIGNEUX A P, et al. The expression of GPIHBP1, an endothelial cell binding site for lipoprotein lipase and chylomicrons, is induced by peroxisome proliferator-activated receptor-gamma ［J］. Mol Endocrinol, 2008, 22(11): 2496-2504.

［38］KLINGER M M, MARGOLIS R U, MARGOLIS R K. Isolation and characterization of the heparan sulfate proteoglycans of brain. Use of affinity chromatography on lipoprotein lipase-agarose ［J］. J Biol Chem, 1985, 260(7): 4082-4090.

［39］NIELSEN M S, BREJNING J, GARCIA R, et al. Segments in the C-terminal folding domain of lipoprotein lipase important for binding to the low density lipoprotein receptor-related protein and to Heparan sulfate proteoglycans ［J］. J Biol Chem, 1997, 272(9): 5821-5827.

［40］SUKONINA V, LOOKENE A, OLIVECRONA T, et al. Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue ［J］. Proc Natl Acad Sci USA, 2006, 103(46): 17450-17455.

［41］GOLDBERG I J. Lipoprotein lipase and lipolysis: Central roles in lipoprotein metabolism and atherogenesis ［J］. J Lipid Res, 1996, 37(4): 693-707.

［42］SONNENBURG W K, YU D, LEE E C, et al. GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4 ［J］. J Lipid Res, 2009, 50(12): 2421-2429.

［43］LIU J, AFROZA H, RADER D J, et al. Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases ［J］. J Biol Chem, 2010, 285(36): 27561-27570.

[1]	李春艳, 张彦, 吕春荣, 邓卫东, 权国波. 褪黑素的抗氧化机制及其在哺乳动物精子冷冻保存中的应用研究进展[J]. 畜牧兽医学报, 2023, 54(11): 4468-4476.
[2]	刘爽, 贺丽霞, 马钧, 冯雪, 杨梦丽, 汪书哲, 杨润军, 房希碧, 咸海龙, 王永康, 张路培, 马云. 固原黄牛遗传背景及其体尺指数、肉用指数分析[J]. 畜牧兽医学报, 2023, 54(6): 2376-2388.
[3]	杨苏坤, 董依萌, 王洪亮, 赵喜堂, 陈旭, 邢秀梅. 基于mtDNA和Y染色体基因片段的塔河马鹿种公鹿遗传多样性分析[J]. 畜牧兽医学报, 2023, 54(6): 2402-2413.
[4]	刘铃, 王丹丹, 崔凯, 马月辉, 蒋琳. 猪繁殖与呼吸综合征抗病育种研究进展[J]. 畜牧兽医学报, 2023, 54(2): 434-442.
[5]	王宏浩, 任小康, 张毅, 高会江, 车雷杰, 王曦. 基因芯片技术在晋南牛种公牛选育中的应用[J]. 畜牧兽医学报, 2021, 52(10): 2803-2813.
[6]	刘晓倩, 靳兰杰, 董艳秋, 李冬杰, 张萃, 谷书凯, 李世杰. DNA甲基化调控牛AQP1基因的胎盘特异性印记[J]. 畜牧兽医学报, 2021, 52(8): 2181-2189.
[7]	郭潇潇, 李隐侠, 王悦, 张含, 张俊, 钱勇, 孟春花, 王慧利, 仲跻峰, 曹少先. 湖羊PLAG1基因5'调控区多态性及其与早期体重的关联分析[J]. 畜牧兽医学报, 2021, 52(2): 331-343.
[8]	郭健康, 樊自尧, 牛鹏霞, 刘志国, 牟玉莲, 张明睿, 李奎, 王冰源. Ide基因通过AKT调控成肌细胞增殖和分化的研究[J]. 畜牧兽医学报, 2020, 51(8): 1784-1794.
[9]	姚大为, 马静, 陈丽丽, 王添祯, 孙欢, 宋文芹, 马毅. 干扰PTEN基因对奶山羊乳腺上皮细胞脂质合成相关基因的转录及脂肪酸组成的影响[J]. 畜牧兽医学报, 2020, 51(4): 851-860.
[10]	崔胜, 林亚秋, 许晴, 朱江江, 王永. 干扰Smad3促进山羊脂肪细胞分化[J]. 畜牧兽医学报, 2020, 51(3): 475-489.
[11]	马静, 姚大为, 杨春蕾, 李秋玲, 王添祯, 陈成彬, 宋文芹, 马毅. 干扰CREB基因对奶山羊乳腺上皮细胞脂质合成相关基因表达及甘油三酯合成的影响[J]. 畜牧兽医学报, 2019, 50(12): 2413-2421.
[12]	张萃, 陈玮娜, 李俊良, 谷书凯, 徐达, 李冬杰, 李世杰. LINC24065在体细胞核移植牛中的异常表达[J]. 畜牧兽医学报, 2019, 50(1): 44-51.
[13]	王冠楠, 赵宇鹏, 陈玮娜, 张萃, 徐达, 李冬杰, 李世杰. Gab1和Sfmbt2基因在成年普通牛8种不同组织中的印记状态分析[J]. 畜牧兽医学报, 2017, 48(6): 1000-1006.
[14]	李丽莎, 彭永东, 郑晓宁, 李祥龙. 山羊PMEL基因启动子活性及转录调控元件分析[J]. 畜牧兽医学报, 2017, 48(5): 826-835.
[15]	王继英, 王彦平, 徐云华, 王诚, 蔺海朝, 呼红梅, 武英, 郭建凤. 鲁莱黑猪肌内脂肪含量、脂肪酸组成及其相关性状分析[J]. 畜牧兽医学报, 2017, 48(4): 585-594.